Gam-COVID-Vac Lyo

Detailed Description: An open two stage non-randomized Phase 1 study with the participation of healthy volunteers. This clinical trial is an open study of safety, tolerability and immunogenicity of the drug «Gam-COVID-Vac Lyo», lyophilisate for the preparation of a solution for intramuscular administration, with the participation of healthy volunteers.